ORTHOPEDIATRICS CORP 8-K

What Happened

• On April 30, 2026, OrthoPediatrics Corp. announced its financial results for the quarter ended March 31, 2026 by issuing a press release. The release includes the company’s unaudited condensed consolidated financial statements and other financial data for the quarter and was furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: April 30, 2026 (Form 8-K, Item 2.02).
• Period covered: quarter ended March 31, 2026 (Q1 2026).
• Exhibit: Press release dated April 30, 2026 furnished as Exhibit 99.1, which contains unaudited condensed consolidated financial statements for the quarter.
• Administrative: Form 8-K signed by Daniel J. Gerritzen, General Counsel and Secretary; Exhibit list included under Item 9.01.

Why It Matters

• The press release and attached financial statements provide the company’s latest quarterly earnings and financial condition—key information for investors tracking revenue, profitability, margins, and cash flow trends. Retail investors should read the Exhibit 99.1 release (or the full 8-K) for the specific numbers and comparisons to prior periods, as those figures can affect valuation and near-term trading decisions.